Clinical Trial: Nuvastatic(R) Phase III Trial for Fatigue in Triple-Negative Breast Cancer

U.S., June 26 -- ClinicalTrials.gov registry received information related to the study (NCT07669467) titled 'Nuvastatic(R) Phase III Trial for Fatigue in Triple-Negative Breast Cancer' on Jan. 07.

Brief Summary: The goal of this clinical trial is to evaluate whether Nuvastatic 300 mg capsules can reduce cancer-related fatigue in adult patients with colon cancer undergoing first-line chemotherapy.

The main questions it aims to answer are:

* Does Nuvastatic 300 mg capsules significantly reduce cancer-related fatigue compared to placebo?

* Is Nuvastatic 300 mg capsules safe and well tolerated in this patient population?

Researchers will compare Nuvastatic 300 mg capsules vs placebo to see if Nuvastatic 300 capsule improves fatigue scores ...